Effects of chronic ingestion of catechin-rich green tea on hepatic gene expression of gluconeogenic enzymes in rats

Biomedical Research

Volumn 30, Issue 1, 2009, Pages 25-29

  Abe, Koichi ^a,b   Okada, Norihisa ^a   Tanabe, Hiroki ^a   Fukutomi, Ryuuta ^c   Yasui, Kensuke ^c   Isemura, Mamoru ^a   Kinae, Naohide ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b KUMIAI CHEMICAL INDUSTRY CO LTD   (Japan)

^c NISSHIN SEIFUN GROUP INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CATECHIN; EPIGALLOCATECHIN; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATASE; GREEN TEA EXTRACT; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRANSCRIPTION FACTOR FKHR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLYCEMIC CONTROL; LIVER WEIGHT; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE STUDY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WEIGHT GAIN; FATTY ACID SYNTHESIS; FLUID INTAKE; GENE EXPRESSION PROFILING; LONG TERM EXPOSURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK REDUCTION; TEA;

ANIMALIA; RATTUS;

ANIMALS; CATECHIN; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE-6-PHOSPHATASE; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TEA; TIME FACTORS;

EID: 66749163495     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.30.25     Document Type: Article

References (24)

1. Abe K, Ijiri M, Suzuki T, Taguchi K, Koyama Y and Isemura M (2005) Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed Res 26, 187-192.
2. Agius L (2007) New hepatic targets for glycaemic control in diabetes. Best Pract Res Clin Endocrinol Metab 21, 587-605.
3. Cabrera C, Artacho R and Giménez R (2006) Beneficial effects of green tea-a review. J Am Coll Nutr 25, 79-99.
4. Fillmore GC, Lin Z, Bohling SD, Robetorye RS, Kim CH, Jenson SD, Elenitoba-Johnson KS and Lim MS (2002) Gene expression profiling of cell lines derived from T-cell malignancies. FEBS Lett 522, 183-188.
5. Gautier-Stein A, Zitoun C, Lalli E, Mithieux G and Rajas F (2006) Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/ vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J Biol Chem 281, 31268-31278.
6. Iso H, Date C, Wakai K, Fukui M and Tamakoshi A (2006) JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144, 554-562.
7. Kang SA, Hong K, Jang KH, Kim YY, Choue R and Lim Y (2006) Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis. J Nutr Biochem 17, 419-426.
8. Khan SA, Priyamvada S, Arivarasu NA, Khan S and Yusuf AN (2007) Influence of green tea on enzymes of carbohydrate metabolism, antioxidant defense, and plasma membrane in rat tissues. Nutrition 23, 687-695.
9. Kitahara A, Toyota T, Kakizaki M and Goto Y (1978) Activities of hepatic enzymes in spontaneous diabetes rats produced by selective breeding of normal Wistar rats. Tohoku J Exp Med 126, 7-11.
10. Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R and Nakamuta M (2007) Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 20, 351-358.
11. Koo MW and Cho CH (2004) Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol 500, 177-185.
12. Koyama Y, Abe K, Sano Y, Ishizaki Y, Njelekela M, Shoji Y, Hara Y and Isemura M (2004) Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med 70, 1100-1102.
13. Kuroda Y and Hara Y (1999) Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436, 69-97.
14. Marzban L, Rahimian R, Brownsey RW and McNeill JH (2002) Mechanisms by which bis (maltolato) oxovanadium (IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo. Endocrinology 143, 4636-4645.
15. McCormack JG, Westergaard N, Kristiansen M, Brand CL and Lau J (2001) Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Curr Pharm Des 7, 1451-1474.
16. Onuma H, Vander Kooi BT, Boustead JN, Oeser JK and O'Brien RM (2006) Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin. Mol Endocrinol 20, 2831-2847.
17. Puskas LG, Nagy ZB, Giricz Z, Onody A, Csonka C, Kitajka K, Hackler L Jr, Zvara A and Ferdinandy P (2004) Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 562, 99-104.
18. Samuel VT, Choi CS, Phillips TG, Romanelli AJ, Geisler JG, Bhanot S, McKay R, Monia B, Shutter JR, Lindberg RA, Shulman GI and Veniant MM (2006) Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55, 2042-2050.
19. Suzuki T, Ishigami Y, Okada N, Kaneko A, Fukutomi R and Isemura M (2008) Differentiation-associated alteration in gene expression of importins and exportins in human leukemia HL-60 cells. Biomed Res 29, 141-145.
20. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M and Granner DK (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933-34940.
21. Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S-388S.
22. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C and Weber P (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 2512-2518.
23. Xu C, Chakravarty K, Kong X, Tuy TT, Arinze IJ, Bone F and Massillon D (2007) Several transcription factors are recruited to the glucose-6-phosphatase gene promoter in response to palmitate in rat hepatocytes and H4IIE cells. J Nutr 137, 554-559.
24. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M and Unterman TG (2006) FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281, 10105-10117.